Optimizing Kitting for Pediatric Cell Therapy Trials

This case study outlines the kitting processes implemented by Precision for Medicine for a Phase I multicenter pediatric cell therapy trial targeting relapsed or refractory solid tumors. The primary research goal was to evaluate the safety and tolerability of autologous TIL therapy, with a focus on ensuring viable and sterile tumor tissue collection. The study faced significant challenges, including the need for immediate and uncompromised sample transfer to the manufacturing site, strict sterility requirements, and regulatory compliance. Precision for Medicine addressed these challenges by employing a precision kitting approach that included custom media preparation and aseptic handling. The results demonstrated rigorous compliance with GLP guidelines, a reduction in site-level errors, and successful temperature-controlled delivery of kits. The case study emphasizes the importance of early kitting involvement and the combination of automation and human expertise in achieving trial success. The successful execution of this kitting strategy contributed to the trial's progression into Phase II.